{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:11:52Z","timestamp":1778033512837,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus Disease 2019 (COVID-19) is a viral pandemic disease that may induce severe pneumonia in humans. In this paper, we investigated the putative implication of 12 vaccines, including BCG, OPV and MMR in the protection against COVID-19. Sequences of the main antigenic proteins in the investigated vaccines and SARS-CoV-2 proteins were compared to identify similar patterns. The immunogenic effect of identified segments was, then, assessed using a combination of structural and antigenicity prediction tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 14 highly similar segments were identified in the investigated vaccines. Structural and antigenicity prediction analysis showed that, among the identified patterns, three segments in Hepatitis B, Tetanus, and Measles proteins presented antigenic properties that can induce putative protective effect against COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results suggest a possible protective effect of HBV, Tetanus and Measles vaccines against COVID-19, which may explain the variation of the disease severity among regions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-021-04045-3","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:03:04Z","timestamp":1616763784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect"],"prefix":"10.1186","volume":"22","author":[{"given":"Sondes","family":"Haddad-Boubaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houcemeddine","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabeb","family":"Touati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaouther","family":"Ayouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Lakhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Ben Mustapha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kais","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Kharrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henda","family":"Triki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"issue":"3","key":"4045_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"G Li","year":"2020","unstructured":"Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"4045_CR2","unstructured":"WHO. WHO Coronavirus Disease (COVID-19) Dashboard 2020 [15 January 2020]. https:\/\/covid19.who.int\/."},{"key":"4045_CR3","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536\u201344.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"4045_CR4","doi-asserted-by":"crossref","unstructured":"Touati R, Haddad-Boubaker S, Ferchichi I, Messaoudi I, Ouesleti AE, Triki H, et al. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: high identity and possible recombination between Bat and Pangolin coronaviruses. Genomics. 2020.","DOI":"10.1016\/j.ygeno.2020.07.003"},{"issue":"7798","key":"4045_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u20139.","journal-title":"Nature"},{"key":"4045_CR6","unstructured":"WHO. Coronavirus disease (COVID-19) weekly epidemiological update 2020 [22 October 2020]. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"issue":"11","key":"4045_CR7","doi-asserted-by":"publisher","first-page":"e1390","DOI":"10.1016\/S2214-109X(20)30387-9","volume":"8","author":"PC Hallal","year":"2020","unstructured":"Hallal PC, Hartwig FP, Horta BL, Silveira MF, Struchiner CJ, Vidaletti LP, et al. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys. The Lancet Global health. 2020;8(11):e1390\u20138.","journal-title":"The Lancet Global health"},{"issue":"Suppl 1","key":"4045_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/s1677-5538.ibju.2020.s101","volume":"46","author":"MA Lauxmann","year":"2020","unstructured":"Lauxmann MA, Santucci NE, Autran-Gomez AM. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. Int Braz J Urol. 2020;46(Suppl 1):6\u201318.","journal-title":"Int Braz J Urol"},{"issue":"9","key":"4045_CR9","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid2609.202095","volume":"26","author":"RB Martines","year":"2020","unstructured":"Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease. US Emerg Infect Dis. 2020;26(9):2005\u201315.","journal-title":"US Emerg Infect Dis"},{"key":"4045_CR10","doi-asserted-by":"crossref","unstructured":"Haider N, Osman AY, Gadzekpo A, Akipede GO, Asogun D, Ansumana R, et al. Lockdown measures in response to COVID-19 in nine sub-Saharan African countries. BMJ Global Health. 2020;5(10).","DOI":"10.1136\/bmjgh-2020-003319"},{"issue":"11","key":"4045_CR11","doi-asserted-by":"publisher","first-page":"e24248","DOI":"10.2196\/24248","volume":"22","author":"LA Post","year":"2020","unstructured":"Post LA, Argaw ST, Jones C, Moss CB, Resnick D, Singh LN, et al. A SARS-CoV-2 surveillance system in Sub-Saharan Africa: modeling study for persistence and transmission to inform policy. J Med Internet Res. 2020;22(11):e24248.","journal-title":"J Med Internet Res"},{"issue":"10","key":"4045_CR12","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/all.14449","volume":"75","author":"C Riggioni","year":"2020","unstructured":"Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, et al. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020;75(10):2503\u201341.","journal-title":"Allergy"},{"issue":"10236","key":"4045_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","volume":"395","author":"N Curtis","year":"2020","unstructured":"Curtis N, Sparrow A, Ghebreyesus TA, Netea MG. Considering BCG vaccination to reduce the impact of COVID-19. Lancet. 2020;395(10236):1545\u20136.","journal-title":"Lancet"},{"issue":"6","key":"4045_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O'Neill","year":"2020","unstructured":"O\u2019Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020;20(6):335\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4045_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.vaccine.2018.12.005","volume":"37","author":"I Vojtek","year":"2019","unstructured":"Vojtek I, Buchy P, Doherty TM, Hoet B. Would immunization be the same without cross-reactivity? Vaccine. 2019;37(4):539\u201349.","journal-title":"Vaccine"},{"key":"4045_CR16","doi-asserted-by":"crossref","unstructured":"Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. JAMA. 2020.","DOI":"10.1001\/jama.2020.8189"},{"issue":"30","key":"4045_CR17","doi-asserted-by":"publisher","first-page":"17720","DOI":"10.1073\/pnas.2008410117","volume":"117","author":"LE Escobar","year":"2020","unstructured":"Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci USA. 2020;117(30):17720\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4045_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fmolb.2020.00120","volume":"7","author":"KR Sidiq","year":"2020","unstructured":"Sidiq KR, Sabir DK, Ali SM, Kodzius R. Does Early Childhood Vaccination Protect Against COVID-19? Front Mol Biosci. 2020;7:120.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"4045_CR19","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1128\/JVI.00083-06","volume":"80","author":"Y He","year":"2006","unstructured":"He Y, Li J, Heck S, Lustigman S, Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. J Virol. 2006;80(12):5757\u201367.","journal-title":"J Virol"},{"issue":"8","key":"4045_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41422-020-0366-x","volume":"30","author":"BZ Zhang","year":"2020","unstructured":"Zhang BZ, Hu YF, Chen LL, Yau T, Tong YG, Hu JC, et al. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients. Cell Res. 2020;30(8):702\u20134.","journal-title":"Cell Res"},{"issue":"4","key":"4045_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"S Xia","year":"2020","unstructured":"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020;30(4):343\u201355.","journal-title":"Cell Res"},{"issue":"49","key":"4045_CR22","doi-asserted-by":"publisher","first-page":"19535","DOI":"10.1073\/pnas.0707830104","volume":"104","author":"T Hashiguchi","year":"2007","unstructured":"Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci USA. 2007;104(49):19535\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4045_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/protein\/11.1.65","volume":"11","author":"DA Dougan","year":"1998","unstructured":"Dougan DA, Malby RL, Gruen LC, Kortt AA, Hudson PJ. Effects of substitutions in the binding surface of an antibody on antigen affinity. Protein Eng. 1998;11(1):65\u201374.","journal-title":"Protein Eng"},{"issue":"3","key":"4045_CR24","doi-asserted-by":"publisher","first-page":"e1831","DOI":"10.1371\/journal.pone.0001831","volume":"3","author":"S Frankild","year":"2008","unstructured":"Frankild S, de Boer RJ, Lund O, Nielsen M, Kesmir C. Amino acid similarity accounts for T cell cross-reactivity and for \u201choles\u201d in the T cell repertoire. PLoS ONE. 2008;3(3):e1831.","journal-title":"PLoS ONE"},{"issue":"5","key":"4045_CR25","doi-asserted-by":"publisher","first-page":"e62216","DOI":"10.1371\/journal.pone.0062216","volume":"8","author":"H Singh","year":"2013","unstructured":"Singh H, Ansari HR, Raghava GP. Improved method for linear B-cell epitope prediction using antigen\u2019s primary sequence. PLoS ONE. 2013;8(5):e62216.","journal-title":"PLoS ONE"},{"issue":"1","key":"4045_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.antiviral.2010.04.006","volume":"87","author":"K Tajiri","year":"2010","unstructured":"Tajiri K, Ozawa T, Jin A, Tokimitsu Y, Minemura M, Kishi H, et al. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antiviral Res. 2010;87(1):40\u20139.","journal-title":"Antiviral Res"},{"issue":"1","key":"4045_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu LL, Suscovich TJ, Fortune SM, Alter G. Beyond binding: antibody effector functions in infectious diseases. Nat Rev Immunol. 2018;18(1):46\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"7821","key":"4045_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","volume":"584","author":"AM Arvin","year":"2020","unstructured":"Arvin AM, Fink K, Schmid MA, Cathcart A, Spreafico R, Havenar-Daughton C, et al. A perspective on potential antibody-dependent enhancement of SARS-CoV-2. Nature. 2020;584(7821):353\u201363.","journal-title":"Nature"},{"issue":"9","key":"4045_CR29","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.mayocp.2020.06.018","volume":"95","author":"LB Baughn","year":"2020","unstructured":"Baughn LB, Sharma N, Elhaik E, Sekulic A, Bryce AH, Fonseca R. Targeting TMPRSS2 in SARS-CoV-2 Infection. Mayo Clin Proc. 2020;95(9):1989\u201399.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4045_CR30","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-020-16638-2","volume":"11","author":"CM Poh","year":"2020","unstructured":"Poh CM, Carissimo G, Wang B, Amrun SN, Lee CY, Chee RS, et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020;11(1):2806.","journal-title":"Nat Commun"},{"key":"4045_CR31","doi-asserted-by":"publisher","first-page":"104353","DOI":"10.1016\/j.meegid.2020.104353","volume":"83","author":"R Cagliani","year":"2020","unstructured":"Cagliani R, Forni D, Clerici M, Sironi M. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses. Infect Genetics Evol. 2020;83:104353.","journal-title":"Infect Genetics Evol"},{"key":"4045_CR32","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.csbj.2020.07.017","volume":"18","author":"J Trigueiro-Louro","year":"2020","unstructured":"Trigueiro-Louro J, Correia V, Figueiredo-Nunes I, Giria M, Rebelo-de-Andrade H. Unlocking COVID therapeutic targets: a structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike. Comput Struct Biotechnol J. 2020;18:2117\u201331.","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"4045_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-92 e6.","journal-title":"Cell"},{"issue":"6","key":"4045_CR34","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.4049\/jimmunol.173.6.4050","volume":"173","author":"Y He","year":"2004","unstructured":"He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, et al. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol. 2004;173(6):4050\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"4045_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/JVI.01691-06","volume":"81","author":"SR Schaecher","year":"2007","unstructured":"Schaecher SR, Mackenzie JM, Pekosz A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol. 2007;81(2):718\u201331.","journal-title":"J Virol"},{"key":"4045_CR36","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","volume":"9","author":"D Uthayakumar","year":"2018","unstructured":"Uthayakumar D, Paris S, Chapat L, Freyburger L, Poulet H, De Luca K. Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front Immunol. 2018;9:2869.","journal-title":"Front Immunol"},{"issue":"6","key":"4045_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea MG, Dominguez-Andres J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375\u201388.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4045_CR38","doi-asserted-by":"publisher","first-page":"102573","DOI":"10.1016\/j.amjoto.2020.102573","volume":"41","author":"NA Patel","year":"2020","unstructured":"Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020;41(5):102573.","journal-title":"Am J Otolaryngol"},{"issue":"7","key":"4045_CR39","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.3928\/19382359-20200615-01","volume":"49","author":"MA Yoldas","year":"2020","unstructured":"Yoldas MA, Yoldas H. Pediatric COVID-19 disease: a review of the recent literature. Pediatr Ann. 2020;49(7):e319\u201325.","journal-title":"Pediatr Ann"},{"issue":"8","key":"4045_CR40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2165\/11204830-000000000-00000","volume":"70","author":"S Dhillon","year":"2010","unstructured":"Dhillon S. DTPa-HBV-IPV\/Hib vaccine (Infanrix hexa): a review of its use as primary and booster vaccination. Drugs. 2010;70(8):1021\u201358.","journal-title":"Drugs"},{"issue":"17\u201318","key":"4045_CR41","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/S0264-410X(02)00145-7","volume":"20","author":"RA Heijtink","year":"2002","unstructured":"Heijtink RA, Bergen P, Melber K, Janowicz ZA, Osterhaus AD. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination. Vaccine. 2002;20(17\u201318):2191\u20136.","journal-title":"Vaccine"},{"issue":"16","key":"4045_CR42","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.vaccine.2009.01.112","volume":"27","author":"SL Tillieux","year":"2009","unstructured":"Tillieux SL, Halsey WS, Sathe GM, Vassilev V. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines. Vaccine. 2009;27(16):2265\u201373.","journal-title":"Vaccine"},{"issue":"1\u20133","key":"4045_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0014-5793(03)00249-7","volume":"540","author":"I Haro","year":"2003","unstructured":"Haro I, Perez S, Garcia M, Chan WC, Ercilla G. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. 2003;540(1\u20133):133\u201340.","journal-title":"FEBS Lett"},{"issue":"21","key":"4045_CR44","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1073\/pnas.85.21.8281","volume":"85","author":"LH Ping","year":"1988","unstructured":"Ping LH, Jansen RW, Stapleton JT, Cohen JI, Lemon SM. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci USA. 1988;85(21):8281\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4045_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/IAI.52.1.293-302.1986","volume":"52","author":"M Harboe","year":"1986","unstructured":"Harboe M, Nagai S, Patarroyo ME, Torres ML, Ramirez C, Cruz N. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun. 1986;52(1):293\u2013302.","journal-title":"Infect Immun"},{"issue":"11","key":"4045_CR46","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.vaccine.2009.01.034","volume":"27","author":"M Seki","year":"2009","unstructured":"Seki M, Honda I, Fujita I, Yano I, Yamamoto S, Koyama A. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guerin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains. Vaccine. 2009;27(11):1710\u20136.","journal-title":"Vaccine"},{"issue":"4","key":"4045_CR47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1046\/j.1365-3083.1996.d01-61.x","volume":"43","author":"HG Wiker","year":"1996","unstructured":"Wiker HG, Nagai S, Hewinson RG, Russell WP, Harboe M. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand J Immunol. 1996;43(4):374\u201380.","journal-title":"Scand J Immunol"},{"issue":"15","key":"4045_CR48","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJMp048217","volume":"351","author":"SL Katz","year":"2004","unstructured":"Katz SL. From culture to vaccine\u2013Salk and Sabin. N Engl J Med. 2004;351(15):1485\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"4045_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/11202760-000000000-00000","volume":"11","author":"JD Croxtall","year":"2009","unstructured":"Croxtall JD, Keating GM. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs. 2009;11(5):349\u201357.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"4045_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310.","journal-title":"J Mol Biol"},{"issue":"6","key":"4045_CR51","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.87.6.2264","volume":"87","author":"S Karlin","year":"1990","unstructured":"Karlin S, Altschul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci USA. 1990;87(6):2264\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4045_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, et al. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells. Cell. 2020;182(1):73-84 e16.","journal-title":"Cell"},{"issue":"W1","key":"4045_CR53","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucl Acids Res. 2020;48(W1):W449\u201354.","journal-title":"Nucl Acids Res"},{"issue":"6","key":"4045_CR54","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1074\/jbc.274.6.3363","volume":"274","author":"AF Kisselev","year":"1999","unstructured":"Kisselev AF, Akopian TN, Woo KM, Goldberg AL. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem. 1999;274(6):3363\u201371.","journal-title":"J Biol Chem"},{"issue":"9","key":"4045_CR55","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz V, Paul S, Andreatta M, Marcatili P, Peters B, Nielsen M. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J Immunol. 2017;199(9):3360\u20138.","journal-title":"J Immunol"},{"key":"4045_CR56","doi-asserted-by":"crossref","unstructured":"Urbanowicz RA, Wang R, Schiel JE, Keck ZY, Kerzic MC, Lau P, et al. Antigenicity and immunogenicity of differentially glycosylated hepatitis C virus E2 envelope proteins expressed in mammalian and insect cells. J Virol. 2019;93(7).","DOI":"10.1128\/JVI.01403-18"},{"issue":"5072","key":"4045_CR57","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1126\/science.1323877","volume":"257","author":"DH Fremont","year":"1992","unstructured":"Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 1992;257(5072):919\u201327.","journal-title":"Science"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-021-04045-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:03:27Z","timestamp":1616763807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4045"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04045-3","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"7 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not include Human participants or Patient data. Hence no ethical approval and consent to participate is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study did not include patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}